IVAX Diagnostics (IVD) Delays 10-K Filing; Sees Q4 Sales of $4.19M
Tweet
Share
E-mailGet Alerts IVD Hot Sheet
Price: $0.53 --0%
Financial Fact:
Basic (in shares): 44.09M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Basic (in shares): 44.09M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
IVAX Diagnostics (AMEX: IVD) delays the filing of its 10-K, requires added time to complete financial statements.
Sees Q4 sales of $4.19 million.
Sees Q4 sales of $4.19 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hanmi Pharm licenses obesity drug to Genentech in $2.3B deal
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
Create E-mail Alert Related Categories
Corporate News, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
